Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q07644 (
polypeptide
)
72,197
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
neural cell adhesion molecule
(
NCAM
) and its polysialic acid moeity (PSA) affect cellular interactions during the development of the nervous system and skeletal muscle.
NCAM
has also been identified in the embryonic heart of various species including humans. However, knowledge regarding the role of
NCAM
and its function-modulating PSA in cardiogenesis is limited. The distribution of
NCAM
and its PSA in the ventricular myocardium of chicken embryos was determined by indirect immunofluorescence staining. The
NCAM
polypeptide
was found throughout the cardiac myocardium. In contrast PSA was located in discrete regions in stage 20 to 44 embryos (during and after septation). Myocardium at the subendocardial regions of the atrioventricular canal and ventricular trabeculae were PSA positive by stage 20. At later stages, transverse sections of the postseptation heart just below the level of the atrioventricular interface revealed a PSA-positive bundle of myocardium in the septum. This bundle was continuous with two branches at a more apical level which in turn were continuous with the PSA-positive subendocardial myocardium lining the left and right ventricles. This pattern of PSA in the myocardium was similar to that of the ventricular conduction system configuration defined in the adult heart. Electron micrographs of the subendocardium of the ventricular septum revealed PSA positivity on myofibril-containing cells with the ultrastructural location of Purkinje fibers. At later stages (35-44) a subset of cells within PSA-positive regions was stained by an antibody against an isoform of the myosin heavy chain found in adult Purkinje fibers. These cells and surrounding tissue lacked PSA in the adult heart. Thus polysialylated
NCAM
may be modulating cell-cell interactions during the development of the ventricular conduction system.
...
PMID:Cardiac expression of polysialylated NCAM in the chicken embryo: correlation with the ventricular conduction system. 142 23
The
polypeptide
composition and glycosylation of soluble isoforms of
neural cell adhesion molecule
(
NCAM
) in developing rat brain, CSF, and plasma were characterized. Soluble
NCAM
in rat brain consisted of several glycosylated isoforms. The degree of glycosylation was developmentally regulated. After desialylation, four polypeptides of M(r) values of approximately 190,000 (s1), 135,000 (s2), 115,000 (s3), and 110,000 (s4) were observed. Polypeptides s1, s2, and s3 were also present in CSF, whereas only s3 and s4 were observed in plasma. Treatment of soluble brain
NCAM
with N-glycosidase F, which removes N-linked carbohydrates, produced polypeptides of M(r) values of approximately 190,000, 125,000, and 108,000-97,000. The monoclonal antibody OB11, which recognizes an epitope on the cytoplasmic part of transmembrane forms of
NCAM
, did not react with any of the soluble isoforms. Purified soluble
NCAM
, consisting mainly of s3, contained an N-terminal sequence identical to that of membrane-associated
NCAM
. Gel filtration of s3 indicated that it was present as a dimer under the chosen conditions.
NCAM
-expressing glioma cells adhered specifically to immobilized soluble
NCAM
. This implies that functionally significant soluble forms of
NCAM
are present in the extracellular fluid.
...
PMID:Characterization of soluble neural cell adhesion molecule in rat brain, CSF, and plasma. 149 10
The
neural cell adhesion molecule
(
N-CAM
) is expressed in a specific spatiotemporal pattern during feather development, suggesting that adhesion mediated by this molecule is involved in feather morphogenesis. To begin to investigate
N-CAM
's function in developing feathers, we determined what forms of
N-CAM
polypeptide
are present and the distribution of polysialic acid (PSA), a carbohydrate moiety that decreases
N-CAM
-mediated cellular adhesion.
N-CAM
in skin appears as a Mr 145-kDa
polypeptide
compared to the 140-kDa brain
N-CAM
polypeptide
, and is encoded by a 6.4-kb mRNA, compared to the 6.1-kb mRNA in brain. Polymerase chain reaction analysis of the exon splicing pattern of skin
N-CAM
shows that the 6.4-kb mRNA band represents two transcripts, with and without a 93-bp insert between exons 12 and 13. Thus, two
N-CAM
polypeptides are expressed in skin, but the 93-bp insert does not account for the larger size of the skin mRNAs and polypeptides. We show that the size difference of the polypeptides is instead due to N-linked oligosaccharides attached to the skin
N-CAM
proteins. The larger size of the skin mRNAs may be due to use of a different transcriptional start site. Staining of skin sections and wholemounts confirms previous descriptions of
N-CAM
in developing feathers, but reveals that
N-CAM
is also present at low levels on epidermal cells as early as stage 29 (E6). We find that PSA is expressed only on a subset of the cells that express
N-CAM
, in particular on dermal cells in the feather rudiments from stage 35-36 (E9-10) and on smooth muscle cells at the base of the filaments from stage 37 (E11) until the latest stage examined (stage 44, E18). The known effects on cell-cell adhesion of amount of
N-CAM
and PSA suggest that the variations we observe in skin may regulate cell-cell interactions that are important in feather development.
...
PMID:Structural variants of the neural cell adhesion molecule (N-CAM) in developing feathers. 153 32
Expression of the
neural cell adhesion molecule
was compared in endplate and non-endplate regions of skeletal muscles of mature and old CBF-1 mice, in order to determine whether age-related changes in neuromuscular morphology were correlated with age changes in
neural cell adhesion molecule
expression. Three muscles were examined: two (soleus and sternomastoid) showed age-related regionalization of nerve terminals as one manifestation of increased synaptic remodelling while the third (diaphragm) did not. Relative
neural cell adhesion molecule
content in these muscles was measured by densitometry of immunoblots after concentration by affinity chromatography. Expression of the major 140,000 mol. wt form of
neural cell adhesion molecule
, which was most abundant in the endplate region, was increased in sternomastoid and soleus of old compared to adult mouse, but was unchanged with age in diaphragm. A 70,000-80,000 mol. wt presumably proteolytic
polypeptide
fragment of
neural cell adhesion molecule
was increased in immunoblots of all old muscles. Immunocytochemical studies of skeletal muscles showed no difference in
neural cell adhesion molecule
cellular distribution in mature vs old mice, but in motor nerve of sternomastoid, the number of
neural cell adhesion molecule
-positive nerve fibers was increased in old mice. Several lines of evidence indicated that partial denervation was rare in old CBF-1 mice, and therefore could not account for the findings above. Selective increase of 140,000 mol. wt
neural cell adhesion molecule
expression in the junctional regions of those muscles of old mice which show neuromuscular remodelling indicates that this adhesion molecule may play a role in the age-related instability of motor nerve terminals.
...
PMID:Neural cell adhesion molecule in aged mouse muscle. 158 22
Through analysis of rat genomic cosmid clones, the 5'-most exon of the rat
neural cell adhesion molecule
(
NCAM
) gene was identified. This exon, here named exon 0, contained the entire 5' untranslated region and the N-terminal signal sequence of the
polypeptide
. Exon 0 was isolated from a 1.6-kilobase (kb) EcoRI-HindIII fragment of rat genomic cosmid clone 9 which was 35 kb in length. This fragment was sequenced and found to contain approximately 940 base pairs (bp) of 5'-flanking sequence, exon 0, which was approximately 245 bp in length, and approximately 400 bp of the following intron 0. By using information derived from this fragment and the pR18 rat
NCAM
cDNA, the transcription initiation sites were determined with two assays. Both primer extensions and nuclease S1 protection assays of postnatal day 7 rat brain RNA identified seven initiation sites within a single 10-bp region at positions -195 to -186 relative to the translation start site. An additional minor site was found at position -329. In the immediate 5' region, no consensus TATA or CCAAT sequences were found. Potential regulatory elements within this region include Sp1 consensus binding sites and also a 178-bp homopurine-homopyrimidine sequence containing several mirror repeats.
NCAM
has multiple transcripts which are regulated in a developmental and tissue-specific fashion. To determine whether these transcripts are initiated at the same sites, transcription initiation sites were analyzed in postnatal day 7 and adult rat brain and also in cultured cell lines of neuronal, glial, and muscle phenotypes. These tissues and cells exhibited distinct
NCAM
transcript populations in Northern (RNA) dot blot analysis. In all cases similar transcription start sites were found, suggesting that all major
NCAM
transcripts have similar or identical initiation sites. These results provide essential information to begin analysis of
NCAM
regulation in different tissues and during development.
...
PMID:Transcription initiation sites and structural organization of the extreme 5' region of the rat neural cell adhesion molecule gene. 169 9
During development of the rat central nervous system,
neural cell adhesion molecule
(
NCAM
) mRNAs containing in the extracellular domain a 30-bp alternative exon, here named VASE, replace RNAs that lack this exon. The presence of this alternative exon between previously described exons 7 and 8 changes the predicted loop structure of the derived
polypeptide
from one resembling an immunoglobulin constant region domain to one resembling an immunoglobulin variable domain. This change could have significant effects on
NCAM
polypeptide
function and cell-cell interaction. In this report we test multiple rat tissues for the presence of additional alternative exons at this position and also examine the regulation of splicing of the previously described exon. To sensitively examine alternative splicing, polymerase chain reactions (PCRs) with primers flanking the exon 7/exon 8 alternative splicing site were performed. Four categories of RNA samples were tested for new exons: whole brain from embryonic day 11 to adult, specific brain regions dissected from adult brain, clonal lines of neural cells in vitro, and muscle cells and tissues cultured in vitro and obtained by dissection. Within the limits of the PCR methodology, no evidence for any alternative exon other than the previously identified VASE was obtained. The regulation of expression of this exon was found to be complex and tissue specific. Expression of the 30-bp exon in the heart and nervous system was found to be regulated independently; a significant proportion of embryonic day 15 heart
NCAM
mRNAs contain VASE while only a very small amount of day 15 nervous system mRNAs contain VASE. Some adult central nervous system regions, notably the olfactory bulb and the peripheral nervous system structures adrenal gland and dorsal root ganglia, express
NCAM
which contains very little VASE. VASE is undetectable in
NCAM
PCR products from the olfactory epithelium. Other nervous system regions express significant quantities of
NCAM
both with and without VASE. Clonal cell lines in culture generally expressed very little VASE. These results indicate that a single alternative exon, VASE, is found in
NCAM
immunoglobulin-like loop 4 and that distinct tissues and nervous system regions regulate expression of VASE independently both during development and in adult animals.
...
PMID:Expression of the unique NCAM VASE exon is independently regulated in distinct tissues during development. 169 51
Developmental patterns of immunoreactivity for the
neural cell adhesion molecule
(
N-CAM
) and alpha 2.8-linked polysialic acid (PSA) were identified in embryonic and postnatal rat heart by immunocytochemistry and immunoblotting. Polyclonal antibodies against
N-CAM
and a monoclonal antibody which recognises only polymers of PSA with a chain length greater than eight units were used. Gold- and alkaline-phosphatase-labelled antibodies were used for detection. The
N-CAM
polypeptide
isoform pattern seen by immunoblotting after endoneuraminidase treatment changed as development progressed. During embryonic development a 160-kDa
polypeptide
isoform was predominant. Around birth, 130-, 160- and 170-kDa
polypeptide
isoforms were found. The expression of the 130- and 170-kDa isoforms diminished until finally, in the adult, weak immunoreactivity for bands of 120-, 130- and 160-kDa was seen. In general the extent and intensity of PSA and
N-CAM
immunostaining in rat heart increased until birth and declined thereafter. Early in development prominent immunostaining for PSA and
N-CAM
was seen in the epicardium while later in development this area was only weakly stained. Initially myocardial cells, endocardial cells and some cells in the atrioventricular cushions were immunoreactive for both PSA and
N-CAM
. Later in development
N-CAM
immunostaining was more prominent than PSA immunoreactivity, reflecting a decrease in
N-CAM
polysialylation, which was also seen by immunoblotting. During innervation of the heart, nerve fibres were strongly immunostained for PSA and
N-CAM
, and this was the only immunostaining seen in adult heart.
...
PMID:Expression of polysialylated N-CAM during rat heart development. 195 10
The major membrane-associated or transmembrane isoforms of the
neural cell adhesion molecule
(
NCAM
) are generated by alternative splicing at the 3' end of the mRNA. Further diversity in
NCAM
structure is observed in the extracellular region of the
polypeptide
, where the insertion of additional amino acid residues can result from alternative splicing events occurring at the exon 7-exon 8 and exon 12-exon 13 junctions. Here we report the characterization of tissue-specific patterns of alternative splicing at the exon 12-exon 13 junction by using the polymerase chain reaction. Nine alternatively spliced sequences in rat heart between exon 12 and exon 13 were identified. Each sequence consisted of different combinations of the three small exons (15, 48, and 42 bp in length) and the AAG triplet that make up MSD1, the 108-bp muscle-specific sequence found in human skeletal muscle
NCAM
(G. Dickson, H.J. Gower, C. H. Barton, H. M. Prentice, V. L. Elsom, S. E. Moore, R. D. Cox, C. Quinn, W. Putt, and F. S. Walsh, Cell 50:1119-1130, 1987). Although the rat equivalent of MSD1 (designated 15+ 48+ 42+ 3+) was detected in all ages of heart examined, it was only one of four or five major splice combinations at any given age. The only alternatively spliced sequence found in the exon 7-exon 8 junction of heart
NCAM
mRNA was the 30-bp variable alternatively spliced exon previously identified in rat brain. Twenty-seven
NCAM
forms with distinct sequences were found by analysis of individual
NCAM
transcripts from postnatal day 1 heart tissue for alternative splicing at the exon 7-exon 8 junction, the exon 12-exon 13 junction and the 3' end. Several combinations of splicing patterns in these three different regions of the gene appeared to be preferentially expressed. The observation that the expression of alternatively spliced forms of
NCAM
is developmentally regulated suggests a role for
NCAM
diversity in cardiac development.
...
PMID:At least 27 alternatively spliced forms of the neural cell adhesion molecule mRNA are expressed during rat heart development. 199 15
The
neural cell adhesion molecule
N-CAM has been identified in a number of species and comprises at least three major cell surface polypeptides of different molecular structures and tissue distributions. We report here the isolation and characterization of cDNA clones encoding two of the three major forms of N-CAM from a human neuroblastoma cDNA library. One of the clones, NII-6, provides the first complete sequence of a small cytoplasmic domain (140 kDa) form of the molecule in humans and differs in a number of respects from cDNA clones derived from human muscle. These differences include the presence of a 30-bp insert in the fourth immunoglobulin-like domain of N-CAM, a 3-bp insert in the extracellular portion of the molecule, and an additional 6 bp in the middle of the membrane-spanning segment. Based on the analysis of a genomic DNA clone spanning these regions of N-CAM, the first two differences arise by alternate splicing of RNA and occur in some, but not all clones; the additional 6 bp may reflect a genetic polymorphism. A second cDNA clone, NI-10, encodes the complete sequence of a segment that is specific to the large cytoplasmic domain (180 kDa)
polypeptide
of human N-CAM and is very similar to corresponding segments of mouse, chicken, and rat N-CAM. This sequence also arises by alternative splicing of RNA. In addition, we have identified a genomic DNA segment encoding sequences specific to the third, small surface domain (120 kDa)
polypeptide
of N-CAM. The data presented here and previously define the DNA sequences of the membrane-bound forms and known variants of human N-CAM. From these sequences, a wide variety of probes can be generated for investigating the expression of particular N-CAM polypeptides in normal and pathological tissues.
...
PMID:Characterization of cDNA clones defining variant forms of human neural cell adhesion molecule N-CAM. 207 78
Two biological domains have been identified in the amino terminal region of the
neural cell adhesion molecule
(
NCAM
): a homophilic-binding domain, responsible for
NCAM
-
NCAM
interactions, and a heparin-binding domain (HBD). It is not known whether these two domains exist as distinct structural entities in the
NCAM
molecule. To approach this question, we have further defined the relationship between
NCAM
-heparin binding and cell adhesion. A putative HBD consisting of two clusters of basic amino acid residues located close to each other in the linear amino acid sequence of
NCAM
has previously been identified. Synthetic peptides corresponding to this domain were shown to bind both heparin and retinal cells. Here we report the construction of
NCAM
cDNAs with targeted mutations in the HBD. Mouse fibroblast cells transfected with the mutant cDNAs express
NCAM
polypeptides with altered HBD (
NCAM
-102 and
NCAM
-104) or deleted HBD (HBD-) at levels similar to those of wild-type
NCAM
. Mutant
NCAM
polypeptides purified from transfected cell lines have substantially reduced binding to heparin and fail to promote chick retinal cell attachment. Furthermore, whereas a synthetic peptide that contains both basic amino acid clusters inhibits retinal-cell adhesion to
NCAM
-coated dishes, synthetic peptides in which either one of the two basic regions is altered to contain only neutral amino acids do not inhibit this adhesion. These results confirm that this region of the
NCAM
polypeptide
does indeed mediate not only the large majority of
NCAM
's affinity for heparin but also a significant portion of the cell-adhesion-mediating capability of
NCAM
.
...
PMID:Structural requirements for neural cell adhesion molecule-heparin interaction. 207 67
1
2
3
4
5
6
7
8
9
Next >>